Report Code : CVMI140520256 | Published Date : May 14, 2025
The global Animal Stem Cell Therapy Market is projected to grow from 920 Mn in 2024 to 3.8 B nby 2031, at a 26% CAGR, driven by the adoption of regenerative medicine in equine and canine osteoarthritis treatment.
Market Segmentation
1.1 By Therapy Type
- Autologous Stem Cells (XX% revenue share):
- Example: VetStem’s canine adipose-derived therapy (85% mobility improvement).
- Price: $2,500–$4,000 per treatment.
- Allogeneic Stem Cells (30%):
- Leader: Aratana’s "off-the-shelf" canine MSC product (2025 launch).
- Induced Pluripotent Stem Cells (iPSC) (XX%):
- Innovation: Kyoto University’s feline kidney disease trials (2027).
1.2 By Application
- Orthopedics (XX% share):
- Canine hip dysplasia (60% of procedures).
- Equine tendon injuries ($6,000/treatment).
- Oncology (20%):
- T-cell therapies for canine lymphoma (40% remission rate).
- Dermatology (XX%):
- Chronic wound healing in horses.
1.3 By Animal Type
- Companion Animals (XX% revenue):
- Dogs: 1.2M stem cell procedures/year (2025).
- Cats: 5x growth potential with new FDA approvals.
- Livestock (15%):
- Racehorse injury recovery (20% faster return to racing).
- Exotic Animals (XX%):
- Zoo-funded tiger joint regeneration projects.
1.4 By Geography
- North America (XX% share): 70% of VetStem’s $180M revenue.
- Europe (XX%): EMA’s 2025 fast-track for equine therapies.
- Asia-Pacific (15%): Japan leads in feline iPSC research.
2. Key Growth Drivers
2.1 Clinical Efficacy
Condition |
Stem Cell Success Rate |
Traditional Treatment |
Canine Osteoarthritis |
78% mobility improvement |
45% (with NSAIDs) |
Equine Tendonitis |
6-month recovery |
12-month recovery |
2.2 Regulatory Support
- FDA’s 2024 V-CAR-T Guidance: Expedites canine cancer therapy approvals.
- EU Animal Health Law: Classifies stem cells as "essential medicines".
2.3 Economic Factors
- Insurance Coverage:
- 55% of US pet insurers now reimburse stem cell treatments.
- Performance Animals:
- Racehorse owners pay $15K+ for premium cell therapies.
3. Competitive Landscape
Company |
Breakthrough |
Market Impact |
VetStem |
50K+ canine treatments |
$180M revenue (2025) |
Aratana |
Off-the-shelf MSCs |
40% cost reduction |
Magellan |
Equine amniotic stem cells |
90% tendon healing rate |
4. Future Outlook (2025–2031)
- 2026: First FDA-approved stem cell drug for feline chronic kidney disease.
- 2028: 3D-bioprinted cartilage for canine hip replacements.
- 2030: 30% of geriatric pets receive preventive stem cell injections.
Reasons To Buy

Scope


Animal Stem Cell Therapy Market Report
- 1. Animal Stem Cell Therapy Market Research Report
- 1.1 Study Objectives
- 1.2 Animal Stem Cell Therapy Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Animal Stem Cell Therapy Market Research Report - Preface
- 2.1 Animal Stem Cell Therapy Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Therapy Type
- 2.1.2 By Application
- 2.1.3 By Animal Type
- 2.1.4 By Region
- 2.1 Animal Stem Cell Therapy Market Research Report – Detailed Scope and Definitions
- 3. Animal Stem Cell Therapy Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Therapy Type, By Application, By Animal Type, By Country
- 3.3. Opportunities – By Therapy Type, By Application, By Animal Type, By Country
- 3.4. Trends – By Therapy Type, By Application, By Animal Type, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Animal Stem Cell Therapy Market Research Report – DROTs Impact Analysis
-
- 4. Animal Stem Cell Therapy Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Animal Stem Cell Therapy Market, By Therapy Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Autologous Stem Cells
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Allogeneic Stem Cells
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Induced Pluripotent Stem Cells (iPSC)
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Orthopedics
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Oncology
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Dermatology
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Companion Animals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Livestock
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Exotic Animals
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8. Animal Stem Cell Therapy Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 9. North America Animal Stem Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 9.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Autologous Stem Cells
- 9.1.2 Allogeneic Stem Cells
- 9.1.3 Induced Pluripotent Stem Cells (iPSC)
- 9.2.1 Orthopedics
- 9.2.2 Oncology
- 9.2.3 Dermatology
- 9.3.1 Companion Animals
- 9.3.2 Livestock
- 9.3.3 Exotic Animals
- 9.4.1 United States
- 9.4.2 Canada
- 9.5 North America Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
- 9.6 Regional Trends Analysis
- 9.7 North America Animal Stem Cell Therapy Market Research Report - Company Profiles
- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Autologous Stem Cells
- 10.1.2 Allogeneic Stem Cells
- 10.1.3 Induced Pluripotent Stem Cells (iPSC)
- 10.2.1 Orthopedics
- 10.2.2 Oncology
- 10.2.3 Dermatology
- 10.3.1 Companion Animals
- 10.3.2 Livestock
- 10.3.3 Exotic Animals
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands and Rest of Europe
- 10.5 Europe Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
- 10.6 Regional Trends Analysis
- 10.7 Europe Animal Stem Cell Therapy Market Research Report - Company Profiles
- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Autologous Stem Cells
- 11.1.2 Allogeneic Stem Cells
- 11.1.3 Induced Pluripotent Stem Cells (iPSC)
- 11.2.1 Orthopedics
- 11.2.2 Oncology
- 11.2.3 Dermatology
- 11.3.1 Companion Animals
- 11.3.2 Livestock
- 11.3.3 Exotic Animals
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & New Zealand
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
- 11.5 Asia-Pacific Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
- 11.6 Regional Trends Analysis
- 11.7 Asia-Pacific Animal Stem Cell Therapy Market Research Report - Company Profiles
- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Autologous Stem Cells
- 12.1.2 Allogeneic Stem Cells
- 12.1.3 Induced Pluripotent Stem Cells (iPSC)
- 12.2.1 Orthopedics
- 12.2.2 Oncology
- 12.2.3 Dermatology
- 12.3.1 Companion Animals
- 12.3.2 Livestock
- 12.3.3 Exotic Animals
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
- 12.5 Latin America Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
- 12.6 Regional Trends Analysis
- 12.7 Latin America Animal Stem Cell Therapy Market Research Report - Company Profiles
- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Autologous Stem Cells
- 13.1.2 Allogeneic Stem Cells
- 13.1.3 Induced Pluripotent Stem Cells (iPSC)
- 13.2.1 Orthopedics
- 13.2.2 Oncology
- 13.2.3 Dermatology
- 13.3.1 Companion Animals
- 13.3.2 Livestock
- 13.3.3 Exotic Animals
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
- 13.5 Middle East and Africa Animal Stem Cell Therapy Market – Opportunity Analysis Index, By Therapy Type, By Application, By Animal Type, and Country, 2024 - 2031
- 13.6 Regional Trends Analysis
- 13.7 Middle East and Africa Animal Stem Cell Therapy Market Research Report - Company Profiles
- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
- 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 14.2.1 StemcellX
- 14.2.2 VetStem Inc.
- 14.2.3 Gallant (formerly Home)
- 14.2.4 Ardent Animal Health
- 14.2.5 InGeneron
- 14.2.6 MediVet Biologics
- 14.2.7 Odyssey Veterinary Care
- 14.2.8 Foothills Pet Healthcare Clinic
- 14.2.9 VetStem Biopharma
- 14.2.10 Celavet Inc.
- 9.1 By Therapy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 15. Data Collection Method and Research Approach
- 16. Principal Presumptions and Acronyms